ICUI ICU Medical
ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
Company profile
Ticker
ICUI
Exchange
Website
CEO
Vivek Jain
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Boston Scientific • Baxter International • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...
SEC CIK
Corporate docs
IRS number
330022692
ICUI stock data
()
News
ICU Medical Q1 EPS $1.62 Beats $1.50 Estimate, Sales $318.00M Beat $300.90M Estimate
6 May 21
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
6 May 21
Earnings Scheduled For May 6, 2021
6 May 21
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
1 May 21
Calendar
7 May 21
27 Jul 21
31 Dec 21
Financial summary
Quarter (USD) |
Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from ICU Medical earnings reports.
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jul 21 | Laurie Hernandez | NQSO Common Stock | Grant | Aquire A | No | No | 208.16 | 1,055 | 219.61K | 1,055 |
| 1 Jul 21 | Laurie Hernandez | Common Stock Common Stock | Grant | Aquire A | No | No | 0 | 352 | 0 | 352 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Sell | Dispose S | No | No | 204.0404 | 207 | 42.24K | 22,973 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Sell | Dispose S | No | No | 202.9479 | 1,293 | 262.41K | 23,180 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Sell | Dispose S | No | No | 204.0815 | 215 | 43.88K | 24,473 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Sell | Dispose S | No | No | 203.067 | 2,485 | 504.62K | 24,688 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Sell | Dispose S | No | No | 202.1567 | 300 | 60.65K | 27,173 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Option exercise | Aquire M | No | No | 39.38 | 1,500 | 59.07K | 27,473 |
| 3 Jun 21 | Robert S Swinney | Common Stock | Option exercise | Aquire M | No | No | 43.62 | 1,500 | 65.43K | 25,973 |
| 3 Jun 21 | Robert S Swinney | NQSO Common Stock | Option exercise | Dispose M | No | No | 43.62 | 1,500 | 65.43K | 0 |
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
93.6% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 272 |
| Opened positions | 36 |
| Closed positions | 37 |
| Increased positions | 99 |
| Reduced positions | 86 |
13F shares |
Current |
|---|---|
| Total value | 6.78B |
| Total shares | 19.86M |
| Total puts | 36.6K |
| Total calls | 132.7K |
| Total put/call ratio | 0.3 |
Largest owners |
Shares | Value |
|---|---|---|
| TROW T. Rowe Price | 2.58M | $529.59M |
| JHG Janus Henderson | 2.43M | $498.37M |
| Vanguard | 1.85M | $379.29M |
| BLK Blackrock | 1.74M | $358.15M |
| Nuance Investments | 1.04M | $212.65M |
| JPM JPMorgan Chase & Co. | 909.14K | $186.77M |
| Findlay Park Partners | 671.14K | $137.88M |
| STT State Street | 511.72K | $105.13M |
| Victory Capital Management | 443.51K | $91.12M |
| Atlanta Capital Management Co L L C | 359.27K | $73.81M |
Financial report summary
?Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
7th grade Avg
|
|
New words:
chargeback, earn, evolving, fulfillment, insurance, matter, mentioned, MSA, onset, recognition, reduction, renal, shutdown, unilateral, unsuccessful
Removed:
adjustment, application, April, arithmetic, assessing, attendance, beginning, border, bought, breach, breached, capitalizing, chain, characterized, childcare, China, clarify, cleaning, closely, Cloud, Codification, commenced, communicate, Computing, conducted, consulting, consummate, contingency, continuously, created, customary, daycare, default, defer, delay, department, dependency, dispose, disrupted, distancing, Dr, economy, eligible, employment, enhanced, entertainment, entity, essential, experienced, fight, final, foot, foregoing, freedom, frequency, governing, guarantee, handle, harm, heightening, hierarchy, hindering, hosting, hygiene, impose, incurrence, initiated, interrupt, investee, irrevocably, June, Lake, lapse, led, lieu, light, limiting, liquidation, Lopez, lost, managing, meeting, merge, modify, movement, national, nature, negatively, negotiate, notably, NovaCath, owed, partner, payroll, peripheral, person, personal, physical, PIV, pose, preliminary, productivity, project, protective, pursue, questionnaire, rational, recent, reclassification, recording, redefinition, redemption, Relief, remotely, remove, repay, representative, restrict, restricting, restrictive, resulted, resulting, retrospective, retrospectively, revaluation, reviewing, Salt, school, screening, separation, shift, social, spread, square, stage, stay, subtopic, SuperCath, Targeted, temperature, timelier, training, Transition, unable, Utah, variety, visitor, warehouse, warrant, Wuhan
Financial reports
10-Q
2021 Q1
Quarterly report
7 May 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
6 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
8 May 20
10-K
2019 FY
Annual report
2 Mar 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
9 Aug 19
10-Q
2019 Q1
Quarterly report
10 May 19
10-K
2018 FY
Annual report
1 Mar 19
Current reports
8-K
Departure of Directors or Certain Officers
7 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
14 May 21
8-K
ICU Medical, Inc. Announces First Quarter 2021 Results
6 May 21
8-K
ICU Medical, Inc. Announces Fourth Quarter 2020 Results
25 Feb 21
8-K
ICU Medical, Inc. Announces Third Quarter 2020 Results and Updates Fiscal Year 2020 Guidance
5 Nov 20
8-K
ICU Medical, Inc. Announces Second Quarter 2020 Results
10 Aug 20
8-K
Submission of Matters to a Vote of Security Holders
14 May 20
8-K
ICU Medical, Inc. Announces First Quarter 2020 Results and Updates Fiscal Year 2020 Guidance
7 May 20
8-K
Departure of Directors or Certain Officers
27 Feb 20
8-K
ICU Medical, Inc. Announces Fourth Quarter 2019 Results
27 Feb 20
Registration and prospectus
S-3ASR
Automatic shelf registration
15 Nov 18
8-A12B/A
Registration of securities on exchange (amended)
26 Feb 18
S-8
Registration of securities for employees
29 Jun 17
S-8
Registration of securities for employees
19 Aug 14
S-8
Registration of securities for employees
29 Jun 11
8-A12B
Registration of securities on exchange
17 Feb 10
S-8
Registration of securities for employees
19 May 04
S-8
Registration of securities for employees
19 May 04
S-8
Registration of securities for employees
13 Jun 02
S-8
Registration of securities for employees
13 Jun 02
Proxies
DEF 14A
Definitive proxy
1 Apr 21
DEF 14A
Definitive proxy
3 Apr 20
DEFA14A
Additional proxy soliciting materials
6 May 19
DEF 14A
Definitive proxy
5 Apr 19
DEF 14A
Definitive proxy
4 Apr 18
DEF 14A
Definitive proxy
9 Apr 17
DEF 14A
Definitive proxy
3 Apr 16
DEF 14A
Definitive proxy
7 May 15
DEFA14A
Additional proxy soliciting materials
28 May 14
DEF 14A
Definitive proxy
27 Apr 14
Other
SD
Conflict minerals disclosure
26 May 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
UPLOAD
Letter from SEC
11 Sep 17
CORRESP
Correspondence with SEC
4 Sep 17
UPLOAD
Letter from SEC
29 Aug 17
CORRESP
Correspondence with SEC
9 Aug 17
UPLOAD
Letter from SEC
26 Jul 17
SD
Conflict minerals disclosure
30 May 17
Ownership
4
ICU MEDICAL / Laurie Hernandez ownership change
9 Jul 21
3
ICU MEDICAL / Laurie Hernandez ownership change
9 Jul 21
4
ICU MEDICAL / ROBERT S SWINNEY ownership change
3 Jun 21
4
ICU MEDICAL / Vivek Jain ownership change
24 May 21
4
ICU MEDICAL / ELISHA W FINNEY ownership change
13 May 21
4
ICU MEDICAL / David F Hoffmeister ownership change
12 May 21
4
ICU MEDICAL / Donald Abbey ownership change
12 May 21
4
ICU MEDICAL / ROBERT S SWINNEY ownership change
12 May 21
4
ICU MEDICAL / David C. Greenberg ownership change
12 May 21
4
ICU MEDICAL / Virginia Ruth Sanzone ownership change
12 May 21
Patents
GRANT
Utility
Medical connectors and methods of use
27 Jul 21
A medical connector for use in a fluid pathway includes a substantially transparent housing having a proximal end with a proximal opening and a distal end with a distal opening, and a cavity extending therebetween.
APP
Utility
Pressure-regulating Vial Adaptors
8 Jul 21
In certain embodiments, a vial adaptor comprises a housing configured to couple the adaptor with a vial, an access channel, a regulator channel, and a regulator assembly.
APP
Utility
Antimicrobial Cap for Luer Connector
8 Jul 21
A male luer cap comprising a male luer, the male luer having a tapered sealing surface configured to mate with a female tapered surface of a female luer connector to form a substantially fluid-tight seal; a distal tip having a recess defined by a recess surface that is distal to the tapered sealing surface; and a water-soluble antimicrobial composition disposed on the recess surface; wherein the male luer is configured such that, when the male cap is mated with a female connector to form a substantially fluid-tight seal, a cavity is formed between the female tapered surface and the recess surface.
GRANT
Utility
System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
6 Jul 21
A system and method for monitoring and delivering medication to a patient.
APP
Utility
Disposable Infusion Fluid Delivery Device for Programmable Large Volume Drug Delivery
1 Jul 21
A disposable electronically controlled infusion pump system includes at least one disposable infusion container and at least one disposable electronically controlled medication pumping system.
Transcripts
2021 Q1
Earnings call transcript
8 May 21
2020 Q4
Earnings call transcript
26 Feb 21
2020 Q3
Earnings call transcript
7 Nov 20
2020 Q2
Earnings call transcript
10 Aug 20
2020 Q1
Earnings call transcript
10 May 20
2019 Q4
Earnings call transcript
27 Feb 20
2019 Q3
Earnings call transcript
11 Nov 19
2019 Q2
Earnings call transcript
8 Aug 19
2019 Q1
Earnings call transcript
10 May 19
2018 Q4
Earnings call transcript
28 Feb 19
Reddit threads
Daily Discussion Thread - May 6th, 2021
6 May 21
Daily Discussion Thread - May 5th, 2021
5 May 21
Daily Discussion Thread - February 25th, 2021
25 Feb 21
Daily Discussion Thread - February 24th, 2021
24 Feb 21
Daily Discussion Thread - February 23rd, 2021
23 Feb 21
Daily Discussion Thread - November 5th, 2020
5 Nov 20
Daily Discussion Thread - November 4th, 2020
4 Nov 20